Breakthrough may help in the treatment of children with hearing loss
A new study from Tel Aviv University (TAU) presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear. The genetic material “replaces” the genetic defect and enables the cells to continue functioning normally.
The scientists were able to prevent the gradual deterioration of hearing in mice that had a genetic mutation for deafness. They maintain that this novel therapy could lead to a breakthrough in treating children born with various mutations that eventually cause deafness.
The study was led by Professor Karen Avraham of the Department of Human Molecular Genetics and Biochemistry at TAU’s Sackler Faculty of Medicine and Sagol School of Neuroscience. The paper was published in EMBO Molecular Medicine on December 22, 2020.
Deafness is the most common sensory disability worldwide. According to the World Health Organization, there are about half a billion people with hearing loss around the world today, and this figure is expected to double in the coming decades. One in every 200 children is born with a hearing impairment, and one in every 1,000 is born deaf. In about half of these cases, deafness is caused by a genetic mutation. There are currently about 100 different genes associated with hereditary deafness.
“In this study we focused on genetic deafness caused by a mutation in the gene SYNE4 – a rare deafness discovered by our lab several years ago in two Israeli families, and since then identified in Turkey and the UK as well,” Professor Avraham reports. “Children inheriting the defective gene from both parents are born with normal hearing, but they gradually lose their hearing during childhood. The mutation causes mislocalization of cell nuclei in the hair cells inside the cochlea of the inner ear, which serve as soundwave receptors and are essential for hearing. This defect leads to the degeneration and eventual death of hair cells.”
“We implemented an innovative gene therapy technology: we created a harmless synthetic virus and used it to deliver genetic material – a normal version of the gene that is defective in both the mouse model and the affected human families,” says Shahar Taiber, one of Professor Avraham’s students on the combined MD-PhD track. “We injected the virus into the inner ear of the mice, so that it entered the hair cells and released its genetic payload. By so doing, we repaired the defect in the hair cells and enabled them to mature and function normally.”
The treatment was administered soon after birth and the mice’s hearing was then monitored using both physiological and behavioral tests. “The findings are most promising,” says Professor Jeffrey Holt from Boston Children’s Hospital and Harvard Medical School, a collaborator on the study. “Treated mice developed normal hearing, with sensitivity almost identical to that of healthy mice who do not have the mutation.”
The scientists are now developing similar therapies for other mutations that cause deafness.
“This is an important study that shows that inner ear gene therapy can be effectively applied to a mouse model of SYNE4 deafness to rescue hearing,” says Professor Wade Chien, MD, from the NIDCD/NIH Inner Ear Gene Therapy Program and Johns Hopkins School of Medicine, who was not involved in the study. “The magnitude of hearing recovery is impressive. This study is a part of a growing body of literature showing that gene therapy can be successfully applied to mouse models of hereditary hearing loss, and it illustrates the enormous potential of gene therapy as a treatment for deafness.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Gene therapy for hearing loss
- Tuesday, April 30: Medical Journal
Nicole Estaphan meets a local mom who has defied the odds and is alive 10 years after a diagnosis of Stage 4 lung cancer, thanks in part to targeted gene therapy ...
- Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Oral presentations include updated results from clinical study of otoferlin gene therapy DB-OTO demonstrating restoration in children with ...
- New gene therapy for metachromatic leukodystrophy proves effective in mice
Metachromatic leukodystrophy is a rare genetic disorder that mainly affects young children and results in severe neurological symptoms accompanied by a loss of motor and intellectual capacities. At ...
- Hearing Loss News
2024 — A novel gene therapy for hearing loss was administered to six children in China in a clinical trial. Each child had an inherited deafness caused by mutations in the OTOF gene, called DFNB9.
- Is Gene Therapy Nearing a Tipping Point?
One example was reported earlier this year, with the progress made by two separate research teams working on gene therapy programs targeting hearing loss. And the FDA has stated that they expect ...
Go deeper with Google Headlines on:
Gene therapy for hearing loss
[google_news title=”” keyword=”gene therapy for hearing loss” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Inner ear gene therapy
- Sensorion Announces its Participation in the American Society of Cell and Gene Therapy (ASGCT) Annual Meeting
MONTPELLIER, France, April 26, 2024 -- ( BUSINESS WIRE )--Regulatory News: ...
- How To Get Water Out of Your Ear
The fluid in the outer or middle ear (otitis media) can become sticky and thick if not treated appropriately. Signs you may have trapped water in your middle ear rather than the external ear canal ...
- Why vertigo happens when people fly
Maintaining balance is a remarkable symphony between our inner ear, eyes, and nervous system. The inner ear, particularly the vestibular system, plays the role of conductor. This intricate network ...
- Ruptured Eardrum: Symptoms and Treatments
What Is a Ruptured Eardrum? Your eardrum (tympanic membrane) is the thin, circular piece of tissue that separates your outer and middle ear. It protects your middle ear from dirt, debris ...
- Middle ear infection more prevalent post Covid
Screening for adenoid hypertrophy recommended. This makes it easier for bacteria and viruses to travel from the nose and throat to the middle ear. Otitis media is an inflammation or infection of ...
Go deeper with Google Headlines on:
Inner ear gene therapy
[google_news title=”” keyword=”inner ear gene therapy” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]